BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 31342906)

  • 21. Web-Based Patient-Reported Outcomes for ENT Patients-Evaluation of the Status Quo, Patients' View, and Future Perspectives.
    Wald T; Zebralla V; Boege M; Kunz V; Neumuth T; Dietz A; Wichmann G; Wiegand S
    Int J Environ Res Public Health; 2022 Sep; 19(18):. PubMed ID: 36142048
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Benefits and Disadvantages of Electronic Patient-reported Outcome Measures: Systematic Review.
    Meirte J; Hellemans N; Anthonissen M; Denteneer L; Maertens K; Moortgat P; Van Daele U
    JMIR Perioper Med; 2020 Apr; 3(1):e15588. PubMed ID: 33393920
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Electronic Patient Reported Outcome Measures for Optimal Remote Symptom Management in Advanced Breast Cancer: Embracing Digital Health Technology.
    Warren M
    Semin Oncol Nurs; 2024 Feb; 40(1):151550. PubMed ID: 38042751
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Patients' experiences of engaging with electronic Patient Reported Outcome Measures (PROMs) after the completion of radiation therapy for breast cancer: a pilot service evaluation.
    Hughes J; Flood T
    J Med Radiat Sci; 2023 Dec; 70(4):424-435. PubMed ID: 37550951
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessing Patient-Reported Outcomes in Routine Cancer Clinical Care Using Electronic Administration and Telehealth Technologies: Realist Synthesis of Potential Mechanisms for Improving Health Outcomes.
    Govindaraj R; Agar M; Currow D; Luckett T
    J Med Internet Res; 2023 Nov; 25():e48483. PubMed ID: 38015606
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A snapshot on radiotherapy for head and neck cancer patients during the COVID-19 pandemic: a survey of the Italian Association of Radiotherapy and Clinical Oncology (AIRO) head and neck working group.
    De Felice F; D'Angelo E; Ingargiola R; Iacovelli NA; Alterio D; Franco P; Bonomo P; Merlotti A; Bacigalupo A; Maddalo M; Di Rito A; Fanetti G; D'Onofrio I; Dionisi F; Miccichè F; Trignani M; Musio D; Paiar F; Romanello DA; Donato V; Orlandi E
    Radiol Med; 2021 Feb; 126(2):343-347. PubMed ID: 33025304
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PROutine: a feasibility study assessing surveillance of electronic patient reported outcomes and adherence via smartphone app in advanced cancer.
    Benze G; Nauck F; Alt-Epping B; Gianni G; Bauknecht T; Ettl J; Munte A; Kretzschmar L; Gaertner J
    Ann Palliat Med; 2019 Apr; 8(2):104-111. PubMed ID: 29156896
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A pilot study of a smartphone-based monitoring intervention on head and neck cancer patients undergoing concurrent chemo-radiotherapy.
    Zini EM; Lanzola G; Quaglini S; Bossi P; Licitra L; Resteghini C
    Int J Med Inform; 2019 Sep; 129():404-412. PubMed ID: 31445284
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A study to evaluate nurse-led on-treatment review for patients undergoing radiotherapy for head and neck cancer.
    Wells M; Donnan PT; Sharp L; Ackland C; Fletcher J; Dewar JA
    J Clin Nurs; 2008 Jun; 17(11):1428-39. PubMed ID: 18093117
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mobile Apps in Oncology: A Survey on Health Care Professionals' Attitude Toward Telemedicine, mHealth, and Oncological Apps.
    Kessel KA; Vogel MME; Schmidt-Graf F; Combs SE
    J Med Internet Res; 2016 Nov; 18(11):e312. PubMed ID: 27884810
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High energy (42-66 MeV reactions) fast neutron dose optimization studies in the head and neck, thorax, upper abdomen, pelvis and extremities.
    Griffin TW; Martz KL; Laramore GE; Thomas FJ; Maor MH; Hendrickson FR; Parker RG; Richter MP; Davis LW
    Radiother Oncol; 1990 Dec; 19(4):307-16. PubMed ID: 2126633
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A narrative review of current evidence supporting the implementation of electronic patient-reported outcome measures in the management of chronic diseases.
    Aiyegbusi OL; Nair D; Peipert JD; Schick-Makaroff K; Mucsi I
    Ther Adv Chronic Dis; 2021; 12():20406223211015958. PubMed ID: 34104376
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quality of life among long-term survivors of head and neck cancer treated by intensity-modulated radiotherapy.
    Chen AM; Daly ME; Farwell DG; Vazquez E; Courquin J; Lau DH; Purdy JA
    JAMA Otolaryngol Head Neck Surg; 2014 Feb; 140(2):129-33. PubMed ID: 24337483
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Progressive resistance training in cachectic head and neck cancer patients undergoing radiotherapy: a randomized controlled pilot feasibility trial.
    Grote M; Maihöfer C; Weigl M; Davies-Knorr P; Belka C
    Radiat Oncol; 2018 Nov; 13(1):215. PubMed ID: 30400971
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Geriatric Assessment as a Predictor of Tolerance, Quality of Life, and Outcomes in Older Patients With Head and Neck Cancers and Lung Cancers Receiving Radiation Therapy.
    VanderWalde NA; Deal AM; Comitz E; Stravers L; Muss H; Reeve BB; Basch E; Tepper J; Chera B
    Int J Radiat Oncol Biol Phys; 2017 Jul; 98(4):850-857. PubMed ID: 28258889
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prospective application of implementation science theories and frameworks to inform use of PROMs in routine clinical care within an integrated pain network.
    Ahmed S; Zidarov D; Eilayyan O; Visca R
    Qual Life Res; 2021 Nov; 30(11):3035-3047. PubMed ID: 32876812
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quality of life assessment in advanced non-small-cell lung cancer patients undergoing an accelerated radiotherapy regimen: report of ECOG study 4593. Eastern Cooperative Oncology Group.
    Auchter RM; Scholtens D; Adak S; Wagner H; Cella DF; Mehta MP
    Int J Radiat Oncol Biol Phys; 2001 Aug; 50(5):1199-206. PubMed ID: 11483329
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Radiotherapy related skin toxicity (RAREST-01): Mepitel® film versus standard care in patients with locally advanced head-and-neck cancer.
    Narvaez C; Doemer C; Idel C; Setter C; Olbrich D; Ujmajuridze Z; Carl JH; Rades D
    BMC Cancer; 2018 Feb; 18(1):197. PubMed ID: 29454311
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Validity and Reliability of the Pediatric Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events.
    Reeve BB; McFatrich M; Mack JW; Maurer SH; Jacobs SS; Freyer DR; Withycombe JS; Baker JN; Castellino SM; Lin L; Lucas NR; Hinds PS
    J Natl Cancer Inst; 2020 Nov; 112(11):1143-1152. PubMed ID: 31999349
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stepping into the real world: a mixed-methods evaluation of the implementation of electronic patient reported outcomes in routine lung cancer care.
    Girgis A; Bamgboje-Ayodele A; Rincones O; Vinod SK; Avery S; Descallar J; Smith A'; Arnold B; Arnold A; Bray V; Durcinoska I; Rankin NM; ; Delaney GP
    J Patient Rep Outcomes; 2022 Jun; 6(1):70. PubMed ID: 35723827
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.